Eyeworld

EW NEWS & OPINION 17 introduced each month. Unfortu- nately, complications associated with IOLs were also beginning to crop up. Surgeons would remove IOLs that were causing complica- tions and simply toss them into the drawer. There was no central labora- tory to analyze these complications, and David immediately recognized the great need for such a facility. He was instrumental in establishing the Center for IOL Research at the Uni- versity of Utah. It was an exciting time to be a fellow involved on the ground floor of the development of this endeavor. David's extensive pathology background as well as his ability to distil large amounts of in- formation was perfect for the direc- tor of this center. David was instrumental in getting the word out to ophthalmic surgeons to send their explanted IOLs and compli- cated cases to the IOL Research Cen- ter for analysis. This work resulted in a seminal review article on the IOL complications, and David truly be- came the "IOL guru." I was a charter member of the original "Apple Korps," David's group of ophthalmic pathology research fellows. David nurtured the development of the ca- reers of many young fellows from around the world. He was a wonder- ful mentor and helped to develop my early career in the field of IOL research and the complications. David was an extremely bright man and a great teacher. His research work in the area of IOL complica- tions led to the development of newer and safer IOL designs, finish, and materials that we use to this day in cataract surgery. David's legacy is a large group of former fellows worldwide who continue to perform the important work that he began. Nick Mamalis, M.D. Equipped with unique and extensive training in ophthalmology and pathology as well as with his special personality, talent, and vision, David Apple's impact on ophthalmology was significant. His novel research has changed and improved the care that we can provide to our patients. Although he contributed to the fields of ophthalmology and pathol- ogy in a variety of ways, his major contribution was in the field of in- traocular lens research. Together with a few close friends, they formed a new research field—the research and development of intraocular lenses. He was "Mr. IOL," and our patients are indebted to him for many advances in the safety and perfection of IOLs. I had the privi- lege of being one of his fellows. I met a unique and extraordinary per- son. During recent years he wasn't healthy, but he didn't let it stop him. In spite of the objective diffi- culties he was always working, thinking, exploring, looking for a way to improve, to solve a problem, and always writing, a book, a chap- ter, a manuscript. Every day came with a new idea for research. It was fascinating to be next to him and to learn from him. What was David Apple for me? He was much more than my mentor; he was a wonder- ful human being, someone who was sensitive and knowledgeable in so many areas; he was interested in everything and everyone; and he was a gifted and popular lecturer. He was a leader but stayed modest; he loved to work with and advance the careers of students and young physi- cians. A few years ago we were fortu- nate to have the chance to celebrate 25 years of his laboratory. The amount of love and admiration that was heaped on him during this evening by so many people was im- pressive and could teach us about his special personality. The world of ophthalmology will miss him, his fellows and students will miss him, his many friends will miss him, but more than everyone, his family will miss him. We will miss him every step of the way, but he will stay in our hearts and thoughts. EW Guy Kleinmann, M.D. September 2011 3360 Scherer Drive, Suite B. St.Petersburg, Florida s 4EL s &AX %MAIL )NFO 2HEIN-EDICALCOM s 7EBSITE WWW2HEIN-EDICALCOM /RIGINALLY $EVELOPED "Y 2OBERT - +ERSHNER -$ -ODIl ED "Y ,OUIS $ .ICHAMIN -$ ,IMBAL 2ELAXING )NCISION -ONA ,ISA $A 6INCI +ERSHNER.ICHAMIN * ,2) ** -ARKERS 8-15248: 30˚ 10.0mm LRI Marker 8-15249: 45˚ 10.0mm LRI Marker 8-15250: 60˚ 10.0mm LRI Marker 8-15251: 75˚ 10.0mm LRI Marker 8-15252: 90˚ 10.0mm LRI Marker Call 800-637-4346 For More Information AIBB 1126.Rev C V I D E O #OME 3EE 5S !T !!/ "OOTH " KershNichLRI13S1126cEWaao.indd 1 8/22/11 10:48 AM Donation page www.ascrsfoundation.org/ individual-donation.html Instructions for donors who wish to give: 1) Fill in your contact information and payment method 2) Choose your In Memoriam donation amount 3) Choose (from the drop-down menu) David J. Apple, MD— DO NOT choose research because your donation will be confused with other donations The Foundation will automatically put your donation into the David J. Apple, MD, In Memorium fund.

• Cover